FILTER
FILTERED INTERVIEW RESULTS
Ricus Grimbeek
PRESIDENT AND CEO, TREVALI MINING
Trevali Mining details progress at its’ flagship asset, the Rosh Pinah zinc mine in Namibia.
Gert Van Niekerk
CHAIRMAN, SOUTH AFRICAN DIAMOND PRODUCERS ORGANIZATION (SADPO)
SADPO, which represents the smaller side of the diamond-producing industry in South Africa, explains how the government must alter the regulatory framework for the industry to regain its former sparkle.
Eira Thomas
PRESIDENT & CEO, LUCARA DIAMOND
Lucara Diamond explains how it has managed throughout the pandemic.
Albert Du Preez
SVP, HEAD OF TOMRA MINING
TOMRA Sorting Mining explains the benefits of sensor-based sorting for mining operations beyond industrial minerals and diamonds.
Themba Mkhwanazi
CEO, KUMBA IRON ORE
Kumba Iron Ore is the largest iron ore producer in Africa and the fourth largest iron ore producer in the world.
Veston Malango
CEO, CHAMBER OF MINES NAMIBIA
The Chamber of Mines for Namibia provides an update on the issues currently affecting the country’s mining sector.
Andrew van Zyl
DIRECTOR AND PRINCIPAL CONSULTANT, SRK CONSULTING
SRK Consulting in Southern Africa explains its strategy to meet trends in the mining sector.
Brett Kimber
CEO, EAZI ACCESS
Eazi Access started in 2003 as an equipment rental business and has grown significantly to provide a complete service offering in both work-at-height and material-handling equipment across Southern Africa.
John Manuell
LOCAL DIVISION MANAGER, ABB
ABB South Africa is responsible for implementing electrical, automation and digital solutions for mining and minerals processing customers within the Southern African region.
John Martin
VICE PRESIDENT OF SOUTHERN AFRICA, KAL TIRE
Kal Tire explains its services for the mining industry in Southern Africa.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
